Feed NGEN
NG
NervGen Pharma Corp. Common stock
NGEN · NASDAQ
$1.71 -1.16% (-$0.02)
1M -9.04%
Market Cap $198.1M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$1.54
9.9% downside
Preț actual
$1.71
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile NGEN sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
0 /100
Expensive P/B 56.98x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 36.13%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 719.57%
ROA 190.08%
Asset turnover 0.00x
Debt
82 /100
Low Debt/Equity 0.00x
Current ratio 1.16x
Int. coverage N/A
Stability
57 /100
Moderate Beta 0.69x
EPS volatility 42.37%
Profitable years 0
Întreabă StockBot despre NGEN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Adam H. Rogers
Employees
8
Headquarters
West Vancouver
Evenimente viitoare
21 AUG.
Earnings
Upcoming earnings report